Keywords
Tourette syndrome
children
How to Cite
Abstract
Over recent decades, the etiopathogenic view of tic disorders has shifted dramatically. Once interpreted mainly through psychological and behavioral frameworks, tics are now understood as multifactorial conditions with genetic, immunological, neurochemical, and environmental determinants. In children, tic disorders represent a heterogeneous set of neurodevelopmental syndromes characterized by recurrent, involuntary motor and/or vocal phenomena that may significantly disrupt academic performance, social functioning, and family life.
References
1. Augustin M., Groth C., Richter A., et al. Comprehensive genetic analysis of Tourette syndrome and related tic disorders reveals novel risk loci and shared genetic architecture. Nature Genetics. 2022;54:984–993.
2. Chang K., Frankovich J., Cooperstock M., et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. Journal of Child and Adolescent Psychopharmacology. 2021;31(2):97–117.
3. Davis L.K., Yu D., Keenan C.L., et al. Partitioning the heritability of Tourette syndrome and obsessive–compulsive disorder reveals differences in genetic architecture. PLoS Genetics. 2020;16(6):e1008176.
4. Gromark C., Hesselmark E., Djupedal I.G., et al. Immunoglobulin and cytokine profiles in pediatric acute-onset neuropsychiatric syndrome: a systematic review and meta-analysis. Brain, Behavior, and Immunity. 2023;108:276–291.
5. Martino D., Ganos C., Pringsheim T.M. Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. International Review of Neurobiology. 2021;143:1–33.
6. Murphy T.K., Brennan E.M., Johnco C., et al. Treatment of pediatric acute-onset neuropsychiatric disorder in a large survey population. Journal of Child and Adolescent Psychopharmacology. 2022;32(3):165–176.
7. Paschou P., Fernandez T.V., Sharp F., et al. Genetic architecture of Tourette syndrome: rare and common variants implicate immune and dopaminergic systems. Molecular Psychiatry. 2021;26:3239–3252.
8. Robertson M.M., Eapen V., Singer H.S., et al. Gilles de la Tourette syndrome. Nature Reviews Disease Primers. 2020;3:16097.
